Regenxbio (RGNX) EPS (Diluted) Growth (3y) (2019 - 2025)
Regenxbio (RGNX) EPS (Diluted) Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn | -35.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35.43% |
| Sep 30, 2025 | 91.01% |
| Jun 30, 2025 | 90.45% |
| Mar 31, 2025 | 25.99% |
| Dec 31, 2024 | -30.08% |
| Sep 30, 2024 | 4.77% |
| Jun 30, 2024 | 90.76% |
| Mar 31, 2024 | -6.33% |
| Dec 31, 2023 | -5.10% |
| Sep 30, 2023 | -1,739.85% |
| Jun 30, 2023 | -1,116.21% |
| Mar 31, 2023 | -1,020.34% |
| Dec 31, 2022 | 122.20% |
| Sep 30, 2022 | -1,129.31% |
| Jun 30, 2022 | -3,314.29% |
| Mar 31, 2022 | -1,163.27% |
| Dec 31, 2021 | 284.82% |
| Sep 30, 2021 | -34.35% |
| Jun 30, 2021 | -1,552.96% |
| Mar 31, 2021 | -34.67% |